← Back to Search

Probiotic

Treatment for Infantile Colic (COLIC Trial)

N/A
Waitlist Available
Led By Parth Shah
Research Sponsored by Evolve BioSystems, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Infants with a diagnosis of infantile colic per Rome IV criteria and reported to cry/fuss for ≥ 3 hours/day, within a 24-hour period as determined by the 24-hour cry/fuss eDiary AND 24 hours of LENA vocalizations
Infants with a gestational period of ≥ 37 to 42 weeks
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to day 14
Awards & highlights

COLIC Trial Summary

To investigate whether B. infantis EVC001 colonization in the infant gut can reduce symptoms of colic

Eligible Conditions
  • Infantile Colic

COLIC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

COLIC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to day 14
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to day 14 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in crying/fussing duration

COLIC Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: TreatmentActive Control1 Intervention
B. infantis EVC001 infant probiotic
Group II: PlaceboPlacebo Group1 Intervention
Lactose

Find a Location

Who is running the clinical trial?

Evolve BioSystems, Inc.Lead Sponsor
7 Previous Clinical Trials
704 Total Patients Enrolled
Robin FlanneryStudy DirectorEvolve BioSystems
1 Previous Clinical Trials
231 Total Patients Enrolled
Parth ShahPrincipal InvestigatorObvio Health
4 Previous Clinical Trials
977 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Mar 2025